Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India Nifty Midcap 150 Index Fund | Axis Nifty 500 Index Fund | |
|---|---|---|
| Category | Index Funds (Equity) | Index Funds (Equity) |
| Plan | Direct | Direct |
| Fund house | Nippon India | Axis |
| NAV | ₹26.4030 | ₹10.6016 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 5.7 years | 2.3 years |
| Expense ratio | 0.4% | 0.2% |
| Stars | ★★★★★ | Not rated |
| Growth Score | 65.10 | — |
Returns
| Nippon India Nifty Midcap 150 Index Fund | Axis Nifty 500 Index Fund | |
|---|---|---|
| 1 month | +5.97% | +9.36% |
| 3 months | −2.56% | +2.54% |
| 6 months | +1.70% | +7.31% |
| YTD | +2.59% | +1.48% |
| 1 year | +1.99% | +1.03% |
| 3 years (CAGR) | +13.69% | — |
| 5 years (CAGR) | +14.45% | — |
| 10 years (CAGR) | — | — |
| Since launch | +18.47% | +2.38% |
Risk
| Nippon India Nifty Midcap 150 Index Fund | Axis Nifty 500 Index Fund | |
|---|---|---|
| Volatility | 18.3% | — |
| Downside volatility | 12.5% | — |
| Sharpe | 0.39 | — |
| Sortino | 0.58 | — |
| Calmar | 0.65 | — |
| Return / risk | 0.75 | — |
| Deepest fall | −21.44% | −18.57% |
| Days to recover | 84 | — |
| Below its high | −3.22% | −0.04% |
Against benchmark
| Nippon India Nifty Midcap 150 Index Fund | Axis Nifty 500 Index Fund | |
|---|---|---|
| Alpha | −0.16% | — |
| Beta | 1.00 | — |
| R² | 100.0% | — |
| Up capture | 99.6% | — |
| Down capture | 100.3% | — |
| Tracking error | 0.0% | — |
| Information ratio | −3.58 | — |
| Treynor | 0.06 | — |
Consistency
| Nippon India Nifty Midcap 150 Index Fund | Axis Nifty 500 Index Fund | |
|---|---|---|
| Best 1-year | +61.47% | +17.52% |
| Middle 1-year | +10.70% | +1.82% |
| Worst 1-year | −6.19% | −9.26% |
| 1-year periods with a loss | 9.3% | 35.6% |
| Middle 3-year | +22.84% | — |
| Positive months | 66.7% | — |
| Best day | +3.95% | +3.94% |
| Worst day | −7.09% | −3.36% |
| Worst 5% day | −1.98% | −1.49% |
| Positive days | 57.0% | 51.3% |
| NAVs a year | 247 | 251 |
SIP of ₹10,000 a month
| Nippon India Nifty Midcap 150 Index Fund | Axis Nifty 500 Index Fund | |
|---|---|---|
| 5-year XIRR | +14.61% | — |
| 5-year value | ₹8,71,366 | — |
| 3-year XIRR | +7.72% | — |
| 1-year XIRR | +5.95% | +9.34% |
Holdings overlap i
| Nippon India Nifty Midcap 150 Index Fund | Axis Nifty 500 Index Fund | |
|---|---|---|
| Nippon India Nifty Midcap 150 Index Fund | — | 20% |
| Axis Nifty 500 Index Fund | 20% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | Nippon India Nifty Midcap 150 Index Fund | Axis Nifty 500 Index Fund |
|---|---|---|
| Laurus Labs Limited | 2.41% | 0.49% |
| The Federal Bank Limited | 2.16% | 0.44% |
| Multi Commodity Exchange of India Limited | 2.09% | 0.43% |
| One 97 Communications Limited | 1.81% | 0.37% |
| The Indian Hotels Company Limited | 1.83% | 0.37% |
| Coforge Limited | 1.83% | 0.37% |
| Persistent Systems Limited | 1.69% | 0.35% |
| Hero MotoCorp Limited | 1.72% | 0.35% |
| Bharat Heavy Electricals Limited | 1.45% | 0.30% |
| IndusInd Bank Limited | 1.42% | 0.29% |
| Life Insurance Corporation Of India | 1.25% | 0.26% |
| AU Small Finance Bank Limited | 1.29% | 0.26% |
| Lenskart Solutions Limited | 1.28% | 0.26% |
| Indus Towers Limited | 1.25% | 0.26% |
| Ge Vernova T&D India Limited | 1.28% | 0.26% |
| Lupin Limited | 1.26% | 0.26% |
| FSN E-Commerce Ventures Limited | 1.23% | 0.25% |
| IDFC First Bank Limited | 1.23% | 0.25% |
| Bharat Forge Limited | 1.23% | 0.25% |
| Aurobindo Pharma Limited | 1.19% | 0.24% |
| Dixon Technologies (India) Limited | 1.18% | 0.24% |
| Info Edge (India) Limited | 1.18% | 0.24% |
| Suzlon Energy Limited | 1.06% | 0.22% |
| Marico Limited | 1.09% | 0.22% |
| Ashok Leyland Limited | 1.06% | 0.22% |
Sectors and company size
| Nippon India Nifty Midcap 150 Index Fund | Axis Nifty 500 Index Fund | |
|---|---|---|
| Large companies | 5.9% | 68.3% |
| Mid companies | 90.7% | 20.5% |
| Small companies | 2.5% | 11.1% |
| Top 10 holdings | 18.4% | 29.7% |
| Largest sector | Pharmaceuticals & Biotechnology 10% | Banks 20% |